Please click for
HARVONI® (ledipasvir 90 mg/sofosbuvir 400 mg),
EPCLUSA® (sofosbuvir 400 mg/velpatasvir 100 mg),
SOVALDI® (sofosbuvir 400 mg), and
VOSEVI (sofosbuvir 400 mg/velpatasvir 100
mg/voxilaprevir 100 mg)

full Prescribing Information, including
BOXED WARNING.

iAssist®

A single, online point for prescribing, confirming patient benefits, submitting prior authorizations (PAs), and enrolling a patient for Support Path resources. Registration is fast and easy—sign up today.

The HARVONI, EPCLUSA, SOVALDI, and VOSEVI co-pay coupons may help eligible patients lower their out-of-pocket costs

Click below to register and read full terms and conditions.

With a co-pay coupon, most eligible patients may pay no more than $5 per co-pay (restrictions apply)

  • Not valid for patients enrolled in government healthcare prescription drug programs, such as Medicare Part D and Medicaid. Patients in the coverage gap known as the "donut hole" also are not eligible
  • The HARVONI, EPCLUSA, SOVALDI, and VOSEVI co-pay coupon programs will cover the out-of-pocket costs for HARVONI, EPCLUSA, SOVALDI, and VOSEVI prescriptions up to a maximum of 25% of the catalog price of a 12-week regimen of HARVONI, EPCLUSA, SOVALDI, or VOSEVI

PATIENTS CAN CALL 1-855-7-MYPATH (1-855-769-7284) TO REGISTER OVER THE PHONE

Complete the intake form now to enroll a patient for access to the full range of resources or call 1-855-7-MYPATH

Please select a product:

HARVONI, the HARVONI logo, EPCLUSA, the EPCLUSA logo, SOVALDI, the SOVALDI logo, SUPPORT PATH, the SUPPORT PATH logo, VOSEVI, the VOSEVI logo, GILEAD and the GILEAD logo are trademarks of Gilead Sciences, Inc., or its related companies. All other trademarks herein are the property of their respective owners.

©2017 Gilead Sciences, Inc. All rights reserved. PTFP0833 7/17

By following this link, you are now leaving www.mysupportpath.com. The site you are entering is not controlled by Gilead Sciences, Inc., and Gilead is not responsible for its content or your use of it.